Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-02-14 4:02 pm Sale | 13G | Graybug Vision, Inc. GRAY | Hatteras Venture Partners IV SBIC, LP | 43,064 0.2% | -1,619,903 (-97.41%) | View |
| 2021-02-12 4:16 pm Purchase | 13G | Graybug Vision, Inc. GRAY | Hatteras Venture Partners IV SBIC, LP | 1,662,967 7.9% | 1,662,967 (New Position) | View |
| 2021-02-12 4:16 pm Sale | 13G | G1 Therapeutics, Inc. GTHX | Hatteras Venture Partners IV SBIC, LP | 1,756,462 4.6% | -259,926 (-12.89%) | View |
| 2020-02-11 4:20 pm Sale | 13G | G1 Therapeutics, Inc. GTHX | Hatteras Venture Partners IV SBIC, LP | 2,016,388 5.4% | -640,869 (-24.12%) | View |
| 2019-02-13 4:51 pm Sale | 13G | G1 Therapeutics, Inc. GTHX | Hatteras Venture Partners IV SBIC, LP | 2,657,257 7.1% | -1,417,954 (-34.79%) | View |
| 2018-02-13 4:36 pm Purchase | 13G | G1 Therapeutics, Inc. GTHX | Hatteras Venture Partners IV SBIC, LP | 4,075,211 14.4% | 4,075,211 (New Position) | View |